UCV medical students publish study on allopurinol and heart attack risk

Medical students from the Universidad César Vallejo (UCV) Trujillo campus have published a systematic review and meta-analysis in the international journal Diabetes & Vascular Disease Research. The study investigated the relationship between allopurinol, a medication used to treat gout by reducing uric acid levels, and the risk of acute myocardial infarction in adults.

Through a random effects model, the researchers identified an association between allopurinol use and an approximately 16 percent reduction in the risk of heart attacks compared to control groups. However, the authors noted that this association lost statistical significance in certain additional analyses.

Because of these variations, the researchers did not conclude that the drug prevents heart attacks, but rather emphasized that the findings open a significant line of research. They highlighted the need for further prospective studies and active comparators to better understand the potential cardiovascular effects of gout treatments.